The Cooper Companies, Inc. (CP60)
FSX
Closed
Oct 8, 2026
Day's Range
48.5252 wk Range
46.01Overview - CP60 - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
10.41B
P/E (Trailing)
‪18.94‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪2.17‬
Price / Book
‪1.25‬
EV / EBITDA
‪12.73‬
Profitability
Gross Margin
‪66.76%‬
Profit Margin
‪13.46%‬
Operating Margin
‪20.82%‬
Return on Assets
‪2.73%‬
Return on Equity
‪6.83%‬
Ownership
Shares Outstanding
190.10M
Float
188.76M
Held by Insiders
‪0.63%‬
Held by Institutions
‪111.92%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪59.47‬
200-Day Avg
‪61.58‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Semi-Annual
Market Cap - CP60 - The Cooper Companies, Inc.
Peers - CP60 - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - CP60 - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets a broad portfolio of contact lenses, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
